ArticleThe Lancet regional health. Western Pacific2024

The impact of sodium glucose co-transporter 2 inhibitors and glucagon-like peptide 1 receptor agonists on insulin utilisation and costs in Australia: a national retrospective observational cross-sectional study.

Peter S Hamblin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.